Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR10 | P46092 | 9/20 | 0.37 |
| ▸ | ITGB3 | P05106 | 7/20 | 0.36 |
| ▸ | ITGAV | P06756 | 7/20 | 0.36 |
| ▸ | ITGA2B | P08514 | 7/20 | 0.36 |
| ▸ | PDE2A | O00408 | 1/20 | 0.35 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.35 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.35 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9055585 | 1.00 | CCR10 (0.37) | CCR10ITGB3ITGAVITGA2BPDE2A | |
| SCHEMBL9054485 | 0.99 | CCR10 (0.37) | CCR10ITGB3ITGAVITGA2B | |
| SCHEMBL9055396 | 0.99 | CCR10 (0.37) | CCR10ITGB3ITGAVITGA2B | |
| SCHEMBL9056677 | 0.90 | ITGB3 (0.39) | CCR10ITGB3ITGAVITGA2B | |
| SCHEMBL9055886 | 0.89 | ITGB3 (0.39) | CCR10ITGB3ITGAVITGA2B | |
| SCHEMBL9055586 | 0.89 | ITGB3 (0.40) | CCR10ITGB3ITGAVITGA2B | |
| SCHEMBL9055066 | 0.87 | ITGB3 (0.39) | CCR10ITGB3ITGAVITGA2B | |
| SCHEMBL9054565 | 0.86 | ITGB3 (0.38) | CCR10ITGB3ITGAVITGA2B | |
| SCHEMBL9054627 | 0.86 | CCR10 (0.39) | CCR10PDE2APDE3BPDE3AP2RY12 | |
| SCHEMBL9055173 | 0.86 | ITGB3 (0.36) | CCR10ITGB3ITGAVITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1996002517-A1 | SUBSTITUTED ARYLSULFONAMIDES, THEIR PREPARATION AND USE AS THROMBIN-INHIBITING MEDICAMENTS | DR. KARL THOMAE GMBH (DE) | 1996-02-01 | — | — | WO | disclosed |